# Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)

Study · id `cardio:ct-nct05780151` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05780151](<https://clinicaltrials.gov/study/NCT05780151>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05780151

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

## Technical summary

Registry record NCT05780151. Randomized; no masking; primary purpose other. Start 2023-07-10 (actual); primary completion 2025-01-21 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 107 participants (enrolled count; ClinicalTrials.gov record NCT05780151, source copy `cardio:ctgov-nct05780151-2025-05-29`, retrieved 2026-10-26)
- Started: 2023-07-10 (actual) (ClinicalTrials.gov record NCT05780151, source copy `cardio:ctgov-nct05780151-2025-05-29`, retrieved 2026-10-26)
- Primary completion: 2025-01-21 (actual) (ClinicalTrials.gov record NCT05780151, source copy `cardio:ctgov-nct05780151-2025-05-29`, retrieved 2026-10-26)
- Completion: 2025-01-21 (actual) (ClinicalTrials.gov record NCT05780151, source copy `cardio:ctgov-nct05780151-2025-05-29`, retrieved 2026-10-26)
- Countries: Denmark; Germany; United Kingdom (ClinicalTrials.gov record NCT05780151, source copy `cardio:ctgov-nct05780151-2025-05-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05780151-2025-05-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)
- Acronym: RADIAL
- Condition: Diabetes Mellitus, Type 2
- Intervention (Other): Methodological intervention
- Intervention (Drug): Toujeo
- Lead sponsor: Mira Zuidgeest
- Lead sponsor class: OTHER
- Collaborator: IMI Trials@Home consortium
- Collaborator class: UNKNOWN
- Collaborator: Innovative Medicines Initiative
- Collaborator class: OTHER
- Collaborator: Sanofi
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Sanofi (`cardio:org-sanofi`)

## Provenance

Content hash: 4d0d15802163026387c0a8a55eef49c01fda52945935bf42520a554588cc4333
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
